
HIV Protease
Os inibidores da protease do HIV são uma classe de medicamentos antirretrovirais que têm como alvo específico a enzima protease do vírus da imunodeficiência humana (HIV). Ao inibir esta enzima, esses compostos impedem o vírus de processar suas poliproteínas em proteínas maduras e funcionais, bloqueando assim a produção de novos virions infecciosos. Os inibidores da protease do HIV são um pilar da terapia antirretroviral altamente ativa (HAART) utilizada para o tratamento do HIV/AIDS. Na CymitQuimica, oferecemos uma variedade de inibidores da protease do HIV para apoiar sua pesquisa em tratamento do HIV, resistência a medicamentos e virologia.
Foram encontrados 447 produtos de "HIV Protease"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Hinnuliquinone
CAS:<p>Hinnuliquinone is an anti-HIV agent.</p>Fórmula:C32H30N2O4Pureza:98%Cor e Forma:SolidPeso molecular:506.59Delavirdine
CAS:<p>Delavirdine, an NNRTI for HIV-1, is used in HAART.</p>Fórmula:C22H28N6O3SCor e Forma:SolidPeso molecular:456.56HIV-1 inhibitor-80
<p>HIV-1inhibitor-80 (compound M44) is an HIV-1 inhibitor with an EC50 of 5-148 nM. It demonstrates excellent metabolic stability and low cytotoxicity in human plasma and liver microsomes.</p>Fórmula:C26H19N7OCor e Forma:SolidPeso molecular:445.475Hypoglaunine D
CAS:<p>Hypoglaunine D, an anti-HIV analogue of Triptonine B, inhibits HIV in H9 cells with an EC50 of 22 μg/ml.</p>Fórmula:C41H47NO19Cor e Forma:SolidPeso molecular:857.81(2S,5S)-Censavudine
<p>(2S,5S)-Censavudine, a potent HIV inhibitor and nucleoside reverse transcriptase blocker.</p>Fórmula:C12H12N2O4Cor e Forma:SolidPeso molecular:248.23CI-39
CAS:<p>CI-39, an NNRTI with EC50 of 3.40 µM, inhibits HIV-1 reverse transcriptase and RNase H, with CC50 >30 µM.</p>Fórmula:C19H18N2O4Cor e Forma:SolidPeso molecular:338.36HIV-1 protease-IN-4
<p>HIV-1 protease-IN-4, a prodrug of atazanavir, delivers 5x AUC & 67x C24 compared to atazanavir.</p>Fórmula:C48H69N7O11Cor e Forma:SolidPeso molecular:920.1Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium
CAS:<p>Tenofovir-C3-O-C12 has a longer half-life, potent anti-HIV effects, and better pharmacokinetics than tenofovir.</p>Fórmula:C29H55N6O5PSiCor e Forma:SolidPeso molecular:626.855VIR-165
<p>VIR-165, a derivative of VIRIP (353-372 of alpha1-antitrypsin), blocks several HIV-1 strains.</p>Fórmula:C109H158N22O25S2Pureza:98%Cor e Forma:SolidPeso molecular:2240.712-Oxocalanolide A
<p>12-Oxocalanolide A is a useful organic compound for research related to life sciences and the catalog number is T125675.</p>Fórmula:C22H24O5Cor e Forma:SolidPeso molecular:368.429HIV-IN-2
CAS:<p>HIV-IN-2 (Compound 100) is a potent inhibitor of HIV, showing potential for research into HIV infection [1].</p>Fórmula:C34H27ClF7N9O3SCor e Forma:SolidPeso molecular:810.14Lopinavir Metabolite M-1
CAS:<p>Lopinavir Metabolite M-1, derived from Lopinavir, inhibits HIV protease (Ki=0.7 pM) and shows antiviral activity in vitro.</p>Fórmula:C37H46N4O6Cor e Forma:SolidPeso molecular:642.78Tenofovir-C3-O-C15-CF3 ammonium
CAS:<p>Tenofovir-C3-O-C15-CF3 (ammonium) has a longer half-life and stronger anti-HIV action, improving pharmacokinetics in vivo.</p>Fórmula:C28H52F3N6O5PCor e Forma:SolidPeso molecular:640.73GLR-19
CAS:<p>GLR-19 is an anti-HIV peptide with demonstrated antiviral activity against HSV-2 [1] [2].</p>Fórmula:C102H194N40O20Pureza:98%Cor e Forma:SolidPeso molecular:2300.89NF279
CAS:<p>P2X1 antagonist</p>Fórmula:C49H36N6Na6O23S6Pureza:98%Cor e Forma:SolidPeso molecular:1407.17CTP518
CAS:<p>CTP518, a deuterated Atazanivir derivative, is a HIV protease inhibitor.</p>Fórmula:C38H52N6O7Pureza:98%Cor e Forma:SolidPeso molecular:719.95Carbovir triphosphate
CAS:<p>Carbovir triphosphate (CBV-TP), a phosphorylated metabolite, serves as a research tool for studying human immunodeficiency virus (HIV) [1].</p>Fórmula:C11H16N5O11P3Cor e Forma:SolidPeso molecular:487.19Indoline
CAS:<p>Compound PDK0239, with CAS No. 496-15-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0239 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.</p>Fórmula:C8H9NCor e Forma:Clear To Yellow LiquidPeso molecular:119.16(+)-Carbovir triphosphate
CAS:<p>(+)-Carbovir triphosphate, Abacavir's active metabolite, studied for HIV-1 resistance and inhibition mechanisms.</p>Fórmula:C11H16N5O11P3Cor e Forma:SolidPeso molecular:487.19HIV p17 Gag (77-85)
CAS:<p>Targeting HIV Gag p17 (77-85) with intracellular Ab cDNA disrupts viral replication pre/post-integration.</p>Fórmula:C44H72N10O15Pureza:98%Cor e Forma:SolidPeso molecular:981.1

